SCHEMBL24136303

SCHEMBL24136303

CCC(C)c1ccc(N2CCCCC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.50
KDM4E B2RXH2 4/20 0.46
MAPT P10636 3/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
HTT P42858 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
TP53 P04637 2/20 0.46
POLB P06746 2/20 0.46
GAA P10253 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
USP2 O75604 1/20 0.46
THRB P10828 1/20 0.46
ALOX15 P16050 1/20 0.46
RECQL P46063 1/20 0.46
HSD17B10 Q99714 1/20 0.46
GFER P55789 1/20 0.44
KCNQ2 O43526 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14703927 0.98 ALDH1A1 (0.51) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL24171010 0.86 TP53 (0.48) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL21917560 0.86 TP53 (0.48) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL11990247 0.85 CHKA (0.56) ALDH1A1KDM4EMAPTL3MBTL1GAA
SCHEMBL19928242 0.84 MEN1 (0.55) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL21917658 0.84 TP53 (0.45) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL11984298 0.84 ALDH1A1 (0.52) ALDH1A1KDM4EMAPTL3MBTL1GAA
SCHEMBL11990304 0.84 ALDH1A1 (0.52) ALDH1A1KDM4EMAPTL3MBTL1GAA
SCHEMBL26039679 0.83 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL20883730 0.82 ADRB1 (0.55) ALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 US disclosed
US-11209365-B1 Thallium-gadolinium-chalcogenide nanodot composition KING ABDULAZIZ UNIVERSITY (SA) 2021-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 ALDH1A1 3877/4885KDM4E 1948/4885MAPT 1700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.